Make sure this fits
by entering your model number.
Product Type: Auto Part
Package Quantity: 1
Package Dimensions: 1.0" (L) x 12.76" (W) x 4.69" (H)
Package Weight: 5.98 lbs
HONDA OEM 12-16 CR-V Air Conditioner-Expansion Valve 80221T0AA01 SellerÂ amp;Â Payment Information Seller name:whiteracingproductsllc_nosSee our other listingsWe Accept: Customer Support If you have questions about the product or your order please contact us via MessagesÂ for assistance. Thank youBusiness Hours:Â 9 am to 5:30 pm est ShippingÂ amp;Â Handling Shipping Service:Please refer the shipping sectionShipping Cost:Please refer the shipping sectionShip-to location:Please refer the shipping sectionOrder Processing Time:15 business daysAbout the Part Part Number: 80221T0AA01 The part or sub-assembly you are purchasing is a Genuine OEM Factory Original part sold by an authorized Genuine OEM parts re-seller. All the Honda listed items that have this caveat are drop shipped directly to you the end user, from the OEM manufacturer. While we make every attempt to keep OEM inventory updated with qty and stock, on the rare occasion the OEM will advise us the item stock is depleted and no longer available. Should this be the case, we will make every effort to source the part, if we are not successful, then a full 100% refund will be issued within 24 hours of ordering. We are not inventorying these Honda OEM parts, if you see the listing and you already know Honda has the part on national back-order, or was recently discontinued, then we will not be able to supply. To be sure of availability, it would be best to message us for current stock prior to bidding. There is also the matter of Core Charges that Honda will apply to some parts, sadly there is no 100% way to know what item has a core charge from Honda until an order is placed with them, if there is a Core charge, we will not ship your order until we have approval from you that the core will be shipped back.About the BrandAbout the SellerWe specialize in all New Old Stock parts.Return PolicyReturn shipping paid by:BuyerItem must be returned within:30 DaysRefund will be given
The Dementia UK Ecosystem (DUKE) brings together leaders from the UK DRI, Dementias Platform UK, the National Institute for Health Research, the pharmaceutical industry, and funders to create a cohesive community, coordinating efforts to accelerate progress in tackling dementia.
Produced by a cross-party group of MPs and Peers in collaboration with Alzheimer’s Society, the 'Fuelling the Moonshot' report is the culmination of a detailed inquiry run by the All-Party Parliamentary Group (APPG) on Dementia, which received evidence from experts and organisations in the field of dementia research. The report makes a case for how the Government’s promised ‘Dementia Moonshot’ funding should be spent to best support research into dementia and neurodegeneration.
Prof Sir David Klenerman, UK DRI Group Leader at Cambridge, and Prof Sir Shankar Balasubramanian have been awarded the 2022 Breakthrough Prize for their development of Next Generation Sequencing. The groundbreaking technology significantly reduced the time and cost associated with sequencing a human genome, revolutionising modern research and medicine.
We accelerate, innovate, deepen and broaden discovery science in dementia, with the goal of filling the huge knowledge gap in this field. We exist to bring forward the day when research benefits people living with and those at risk of dementia.
We have a clearly defined vision at the UK DRI to develop effective therapeutics, diagnostics and technologies for people living with dementia. Alongside building our disease knowledge over the coming years, we will also make progress in translating these discoveries into the clinic.
We study a range of neurodegenerative disorders that cause dementia. Many of them share fundamental disease mechanisms and characteristics, and greater understanding gained in one can often benefit others. To ensure we capitalise on diverse expertise, approaches and perspectives, we have established cross-centre themes.
Our efforts to increase the diversity of our team, ensure inclusion and promote equality of opportunity, align with our vision for the UK DRI’s Institute culture and identity as a world-leader in dementia research.